ADRENALINE FOR ANAPHYLAXIS
|
|
- Emery Wells
- 6 years ago
- Views:
Transcription
1 ADRENALINE FOR ANAPHYLAXIS WHAT IS THE EVIDENCE?, MB ChB, FCPaed, Dip Allerg, MMed, PhD Division of Allergy, Department of Paediatrics & Child Health, University of Cape Town and Red Cross War Memorial Children s Hospital, Cape Town, South Africa International and local anaphylaxis guidelines prominently include the use of intramuscular adrenaline. However the evidence for its use is poor and the use of adrenaline in anaphylaxis is based largely on extrapolation from first principles, expert opinion and tradition. Data from basic sciences show the mechanisms of anaphylaxis are potentially amenable to therapy by adrenaline. The early use of adrenaline improves survival in animal models of anaphylaxis but delayed administration is ineffective. Studies of fatal and near-fatal anaphylaxis in humans delineate risk factors for anaphylaxis such as pre-existing asthma, a current asthma attack, food allergies (particularly peanuts, tree nuts and shellfish), reaction to trace amounts of foods and use of non-selective β-blockers. Most reactions occur in individuals with known food allergy and with accidental ingestion. Most studies of fatal anaphylaxis show that a lack or delay in administration of adrenaline is a frequent factor in death whereas early administration of adrenaline even in severe attacks is associated with survival. However, self-injectable adrenaline is underused even when it is available. Incorrect administration may also be an important factor, particularly with adrenaline given by needle and syringe rather than by autoinjector. Autoinjectors should be more widely available and teachers should be trained in the management of anaphylaxis and schools mandated to keep all appropriate emergency medication for named children at risk for anaphylaxis. Up until 2007, guideline-based treatment approaches in different parts of the world were in agreement on the broad principles of management of anaphylaxis, but there were important variations in relation to the treatments to be used and the dose and route of administration of these preparations. 1 Furthermore anaphylaxis guidelines were reported to be in use in only 70% of 44 responding countries polled by the World Allergy Organisation (WAO) in This situation was remedied in 2011 with the publication of the WOA Guidelines for the Assessment and Management of Anaphylaxis. 3 This guideline focuses on the importance of a prompt clinical diagnosis and on the basic initial treatment that is urgently needed and should be available in all settings. This includes having a written emergency protocol and rehearsing it frequently, which must include promptly and simultaneously calling for help, injecting adrenaline intramuscularly and placing Correspondence: Dr M Levin, michael.levin@uct.ac.za the patient on their back with the lower limbs elevated. Additional steps include providing high flow oxygen, maintaining the airway, establishing intravenous (IV) access and giving fluid resuscitation, and where necessary commencing cardiopulmonary resuscitation (CPR). Prevention of recurrence is given prominence with the correct identification of trigger factors and either avoidance or immunomodulation or both, as well as the provision of a patient identification disc/bracelet (e.g. MedicAlert), an action plan (Fig. 1) and patientheld emergency adrenaline, preferably via autoinjector. Fig. 2 gives the step-by-step instructions on use of the adrenaline autoinjector. In addition to this international guideline, 4 the use of adrenaline is universally accepted in national anaphylaxis guidelines across the world, 4,5 and in South Africa at both hospital, 6,7 and primary health care level. 8 However, the evidence for its use is poor and a metaanalysis of studies on adrenaline merely states that such studies have never been done. 9 Conducting research is difficult when conditions are uncommon, acute in onset and short-lived. These challenges are compounded when there is no simple universally agreed upon definition and where rapid and reliable laboratory tests are not available. In addition, conducting randomised trials would be unethical and such studies have never been performed because prompt treatment with adrenaline is deemed to be critically important for survival in anaphylaxis. Thus unavoidably the use of adrenaline in anaphylaxis is based largely on extrapolation from first principles, expert opinion and tradition, but some data do exist to strongly support the use of adrenaline from anaphylaxis, in studies of basic science, in animal model studies and in studies of fatal and near-fatal anaphylaxis. The mechanisms of anaphylaxis are well known and include markedly decreased venous tone and fluid extravasation causing reduced venous return (mixed hypovolaemic-distributive shock) as well as markedly decreased myocardial function. Aggressive fluid resuscitation is required to reverse shock, and adrenaline is given to counter these pathological mechanisms by increasing vascular tone, myocardial contractility and cardiac output. 10 In a study of anaphylaxis in guinea-pig lung, histamine release could be blocked by administration of adrenaline. 11 In addition, the effects of anaphylaxis on reducing ureteric peristalsis during established anaphylactic shock in dogs can be reversed by the administration of adrenaline. 12 The effects of withholding treatment or of differential responses to alternative treatments cannot be conducted in humans. However animal models of Current Allergy & Clinical Immunology, August 2012 Vol 25, No.3 117
2 (Patient / Parent / Guardian Name and Signature) (Date) Fig. 1. ALLSA anaphylaxis action plan may be modified for individual patients. anaphylaxis have looked at the choice of treatment of anaphylaxis and the timing of medication use, and they strongly support the early use of adrenaline. Anaphylactic shock is sometimes fatal or resistant to therapy in patients treated with propranolol, a nonselective β-adrenoceptor antagonist used in cardiovascular diseases. An animal model of anaphylaxis in rats aimed to assess the role of β 2 -antagonists and used adrenaline as salvage treatment. 13 The survival rate of the rats pre-treated with propranolol, the selective β 2 -adrenoceptor antagonist ICI or adrenalectomy was significantly smaller than that with the selective 118 Current Allergy & Clinical Immunology, August 2012 Vol 25, No.3
3 Fig. 2. Directions for use of adrenaline autoinjector (reproduced with permission). β 1 -adrenoceptor antagonist atenolol indicating that inhibition of β 2 -adrenoceptor causes more detrimental effects than that of the β 1 -adrenoceptor. Adrenaline prevented death 100%, even in atenolol-pretreated rats indicating an excellent response to therapy, but merely delayed death in adrenalectamised rats, implying that a degree of endogenous adrenaline is also necessary in the response to anaphylaxis. A further two studies of anaphylaxis in rats compared the effects of arginine vasopressin, adrenaline and terlipressin in increasing mean arterial pressure in an ovalbumin-sensitised anaesthetised anaphylactic shock rat model. In the first study, 14 both arginine vasopressin (AVP) and adrenaline were effective but terlipressin was not. The second study 15 randomly allocated rats to saline (no-treatment group), two boluses of adrenaline followed by continuous infusion (adrenaline group), AVP bolus followed by continuous infusion (AVP group) or adrenaline bolus followed by AVP continuous infusion (adrenaline + AVP group). In the no-treatment group and the AVP alone group no rats survived. Both the adrenaline alone group (84% survival) and the adrenaline + AVP group (100%) had excellent survival, indicating that adrenaline must still be considered as the first-line drug to treat anaphylactic shock. Early administration of adrenaline is suggested for the treatment of anaphylaxis because of the belief that delayed administration of adrenaline may be ineffective because anaphylactic shock becomes refractory to treatment. An animal model of ragweedinduced anaphylaxis in dogs compared no treatment with the effects of administering adrenaline by the IV, subcutaneous (SC) and intramuscular (IM) route. 16 This study assessed whether adrenaline is effective when given late at time of maximal hypotension. However in this circumstance adrenaline failed to cause haemodynamic recovery in fully developed canine anaphylactic shock and all the dogs died. This supports the hypothesis that anaphylaxis becomes refractory to adrenaline if treatment is given late and is in concert Current Allergy & Clinical Immunology, August 2012 Vol 25, No.3 119
4 with the data in studies of fatal anaphylaxis in humans showing that late administration may be futile. Nine large studies have been done on fatal and nearfatal anaphylaxis, 4 in the UK, (Pumphrey, 17 Pumphrey and Gowland, 18 Colver et al., 19 Uguz et al. 20 ), 3 in the USA (Bock et al., 21,22 Sampson et al. 23 ) and 2 in Australia (Gold and Sainsbury, 24 Liew et al. 25 ). As most of these studies are primarily epidemiological they do help to identify high-risk groups for anaphylaxis, and some of the studies contain information that supports the use of adrenaline. Bock et al. 21 showed that of 32 fatal cases of anaphylaxis all but 1 were known to have food allergy before the event (and were at high risk), all but 1 had asthma (a high-risk condition for anaphylaxis in the setting of food allergy), all were accidental ingestions and most notably only 3 of the 32 were given adrenaline. A follow-up of a further 31 subjects between 2001 and showed similar findings: all had asthma and only 4 had adrenaline administered in a timely manner. Sampson et al. 23 studied 13 patients with fatal and near-fatal anaphylaxis in Similar to Bock et al. s findings, 12 of the 13 had asthma, all had food allergies and had accidental ingestions. Of the 6 who died only 2 received adrenaline in the first hour. All the patients who survived (bar 1) had adrenaline within 30 minutes of the reaction. Gold and Sainsbury 24 (2000) interviewed 51 parents of children with milder grades of anaphylaxis. Children had experienced on average 0.98 allergic reactions per child per year since receiving EpiPen prescription. Of these 63% were classified as anaphylaxis (but only about 16% severe anaphylaxis with loss of consciousness and perhaps a further 28% with moderate anaphylaxis in that there was fainting/dizziness). No deaths occurred, and this could not be used as an outcome measure. Children in whom the EpiPen was used were less likely to be given adrenaline in hospital and to require subsequent admission, suggesting that when used in milder grades of anaphylaxis it prevents morbidity. Pumphrey 17 (1999) studied 123 deaths due to anaphylaxis after studying patient folders of 164 fatalities from 1992 to All food-allergic fatal reactions caused difficulty in breathing. Food-related fatal anaphylaxis that caused difficulty in breathing was often inappropriately treated as asthma rather than anaphylaxis. Only 20% of patients given adrenaline received this before they arrested, implying that adrenaline given late is of little value in reversing established anaphylaxis, and early administration is vital. A follow-up of a further 48 cases of fatal anaphylaxis between 2001 and showed that most had asthma and almost a third were undergoing an asthma exacerbation leading up to the fatal reaction. Over half had had no professional advice related to their food allergy. Adrenaline autoinjector (EpiPen) had been provided to 40% of patients but over half of the deaths occurred in patients in whom previous reactions had been so mild that it was unlikely that a doctor would recommend they carry an EpiPen. Pens were used correctly by 9 subjects (19%), but 2 had time-expired and 6 may have failed to deliver an IM injection because of the depth of SC adipose tissue. Pens were used too late in the reaction by 5 subjects, were not carried on that occasion by 4 subjects and were misused by 1. Colver et al. 19 (2005) studied 229 cases of hospital admissions for food-allergic reactions in the UK and Ireland from 1998 to Fifty-eight cases were severe but not fatal. Three were fatal and 6 categorised as near-fatal. Of these 9 fatal and near-fatal cases, 8 had asthma and wheezing was the life-threatening symptom. Eight of the 9 (89%) had experienced a prior food-allergic reaction. Seven of 171 non-severe and 6 of 58 severe cases might have had a worse outcome if adrenaline autoinjectors had been unavailable. Six of the severe cases might have benefited if autoinjectors had been more widely prescribed. Uguz et al. 20 (2005) analysed self-completed questionnaire responses in the UK over a 6-month period from 109 people who had suffered severe allergic reactions. Of 126 reactions reported, 75 were in children under 16 years. Food was implicated in 112 (89%) cases. Children with asthma had more severe reactions than those without asthma, but in this study recent asthma symptoms were not associated with severity of allergic reaction reported. Self-injectable adrenaline was underused even when it was available. In only 35% of severe reactions and 13% of non-severe reactions did patients who had adrenaline administer it! Despite the international guidelines, adrenaline is currently underutilised and often dosed suboptimally to treat anaphylaxis and is underprescribed for potential future self-administration. 5 As of 2008, however, except for adrenaline in ampoule formulation, life-saving essentials for the assessment and management of anaphylaxis in health care settings were not universally available worldwide. 2 Adrenaline given via needle and syringe is not an ideal treatment for ambulatory therapy carried by patients or parents. In experimental (nonanaphylaxis) settings 26 parents are slower at drawing up adrenaline via a needle and syringe and the dose obtained is inaccurate, varying up to 40-fold from the intended dose. In addition to being inaccurate, parents take an average of 142 seconds +/- 13 seconds to draw up and administer adrenaline. It is likely that in stressful anaphylaxis settings even more inaccuracy and delay may be present. In South Africa all the medication polled by the WAO is available; however cost constraints mean that access to vital precautionary adrenaline autoinjector therapy is not widely available. Substantial advocacy regarding the availability of adrenaline autoinjectors and public awareness of anaphylaxis and its treatment particularly at schools is necessary if we are to appropriately manage the burgeoning food allergy epidemic. This should include legislation from the department of education that makes it necessary for all teachers to be trained in the management of anaphylaxis and that schools be mandated to keep all appropriate emergency medication for named children at risk for anaphylaxis. Allergy clinics at state institutions should motivate to drug and therapeutic committees to have autoinjectors available to subjects at high risk of food or venom anaphylaxis. The author declares no conflict of interest. 1. Alrasbi M, Sheikh A. Comparison of international guidelines for the emergency medical management of anaphylaxis. Allergy 2007;62(8): Simons FER. World Allergy Organization survey on global availability of essentials for the assessment and management of anaphylaxis by allergy-immunology specialists in health care settings. Ann Allergy Asthma Immunol. 2010;104(5): Simons FER, Ardusso LRF, Bilò MB, et al. World Allergy Organization Guidelines for the Assessment and Management of Anaphylaxis. World Allergy Organization Journal 2011;4(2): Current Allergy & Clinical Immunology, August 2012 Vol 25, No.3
5 4. Muraro A, Roberts G, Clark A, et al. The Management of Anaphylaxis in Childhood: Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 2007; 62(8): Kemp SF, Lockey RF, Simons FE. World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008;63(8): Standard Treatment Guidelines and Essential Medicines List: Hospital Level, Adults. 2nd ed. Pretoria: National Department of Health, Standard Treatment Guidelines and Essential Drugs List for South Africa, Hospital Level, Paediatrics. 2nd ed. Pretoria: National Department of Health, Standard Treatment Guidelines and Essential Medicines List: Primary Health Care. 4th ed. Pretoria: National Department of Health, Sheikh A, Shehata YA, Brown SG, Simons FE. Adrenaline for the treatment of anaphylaxis: Cochrane Systematic Review. Allergy 2009;64(2): Brown SG. The pathophysiology of shock in anaphylaxis. Immunol Allergy Clin North Am 2007;27(2): Broder I, Baumal R. Studies of reversed anaphylaxis in the perfused guinea-pig lung. Immunology 1972; 22(4): Kiersz J. Changes in spontaneous ureteral peristalsis in experimental shock with and without administration of adrenaline during shock. Int Urol Nephrol 1982;14(3): Zhang W, Shibamoto T, Kurata Y, Kohno H. Effects of β-adrenoceptor antagonists on anaphylactic hypotension in conscious rats. Eur J Pharmacol 2011;650(1): Dewachter P, Jouan-Hureaux V, Lartaud I, et al. Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats. Anesthesiology 2006;104(4): Dewachter P, Raëth-Fries I, Jouan-Hureaux V, et al. A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock. Anesthesiology 2007;106(5): Bautista E, Simons FE, Simons KJ, et al. Epinephrine fails to hasten hemodynamic recovery in fully developed canine anaphylactic shock. Int Arch Allergy Immunol 2002;128(2): Pumphrey RS. Lessons for management of anaphylaxis from a study of fatal reactions. Clin Exp Allergy 2000;30(8): Pumphrey RS, Gowland MH. Further fatal allergic reactions to food in the United Kingdom, J Allergy Clin Immunol 2007;119(4): Colver AF, Nevantaus H, Macdougall CF, Cant AJ. Severe foodallergic reactions in children across the UK and Ireland, Acta Paediatr 2005;94(6): Uguz A, Lack G, Pumphrey R, et al. Allergic reactions in the community: a questionnaire survey of members of the anaphylaxis campaign. Clin Exp Allergy 2005;35(6): Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001;107(1): Bock SA, Muñoz-Furlong A, Sampson HA. Further fatalities caused by anaphylactic reactions to food, J Allergy Clin Immunol 2007;119(4): Sampson HA, Mendelson L, Rosen JP. Fatal and near-fatal anaphylactic reactions to food in children and adolescents. N Engl J Med 1992;6;327(6): Gold MS, Sainsbury R. First aid anaphylaxis management in children who were prescribed an epinephrine autoinjector device (EpiPen). J Allergy Clin Immuno. 2000;106(1 Pt 1): Liew WK, Williamson E, Tang ML. Anaphylaxis fatalities and admissions in Australia. J Allergy Clin Immunol 2009;123(2): Simons FE, Chan ES, Gu X, Simons KJ. Epinephrine for the outof-hospital (first-aid) treatment of anaphylaxis in infants: is the ampule/syringe/needle method practical? J Allergy Clin Immunol 2001;108(6): SPEAKING FOR PEOPLE WHO CANNOT SPEAK FOR THEMSELVES The MedicAlert Foundation is a non profit emergency medical information and identification organisation founded in 1956; headquartered in the United States it has international affiliates in nine countries. The MedicAlert South Africa headquarters are located in Cape Town and has a partnership with ER24. Their mission is to protect and save lives. As a trusted third party custodian of comprehensive personal health information, Medic Alert provides a complete life saving system built around a repository of health information that enables members to manage their personal health records while maintaining security, privacy and confidentiality. The Medic Alert repository can connect to and provide critical medical information between patients, providers and first responders 24 hours a day anywhere in the world. Speedy and efficient medical care, especially in emergency situations, is essential to saving lives. Emergency Medical Services, paramedics, nurses, doctors and other health professionals are often forced to take critical decisions under difficult circumstances and in most cases without access to all the information they would like to have. For a MedicAlert member wearing a Medic Alert identification emblem, one call could save a life! In an emergency it may be just as vital to know who the next of kin is as it it to know the medical details. Each MedicAlert product carries the instantly recognisable international emblem of the Medic Alert Foundation, with the reverse side engraved with basic vital medical information, such as allergies and chronic conditions. Also engraved on the reverse side is the 24 hour telephone hotline number which emergency personnel can call to obtain more detailed medical information by quoting the wearer s unique confidential membership number. There are 200 plus medical conditions and allergies (25 of them chronic). All health professionals should advise their patients of the importance of wearing an identification emblem at all times. It is in the interest of the patients and the medical profession as a whole. Wearing one of MedicAlert s identification emblems is a life saving start for all people who : have any type of hidden medical condition have an allergy have had any type of implant pace maker, heart valve, organ transplant, joint replacement, etc. take regular medication would like their blood group to be recorded have a living will or wish to be an organ/body donor simply want someone else to know if they have been involved in an accident. For more information visit or phone Current Allergy & Clinical Immunology, August 2012 Vol 25, No.3 121
6 TREATMENT OF SEVERE ANAPHYLACTIC REACTIONS (ADULT AND CHILD) ACUTE RESPIRATORY DIFFICULTY (progressive swelling, stridor, wheezing, distress) and/or SIGNS OF SHOCK/HYPOTENSION (especially if skin changes are present) ADRENALINE (1 mg/ml 1:1000) >12 yrs 0.5 ml IM 6-12 yrs 0.3 ml IM <6 yrs 0.15 ml IM Repeat every 5-15 minutes if no improvement OXYGEN MONITORS IV ACCESS High flow oxygen Maintain patent airway (Intubate/cricothyrotomy if necessary) BP, Sats, ECG monitoring High flow IV line PROMETHAZINE (Antihistamine) >12 yrs 25 mg IM or slow IV 6-12 yrs 12.5 mg IM or slow IV 2-6 yrs 6.25 mg IM or slow IV (Avoid if <2 yrs old) CRYSTALLOID Rapid infusion of 1-2 litres (20 ml/kg for children) if no response to adrenaline. Repeat IV infusion as necessary, as large amounts may be required. Adrenaline infusion (0.1-1 μg/kg/min) ONLY if unresponsive to IM adrenaline and fluids NEBULISED BRONCHODILATORS (if severe bronchospasm) Salbutamol >6 yrs 5 mg every mins <6 yrs 2.5 mg every mins WITH Ipratropium >6 yrs 0,5 mg every mins <6 yrs 0,25 mg every 15-20mins H2-RECEPTOR ANTAGONIST Ranitidine Adult 50 mg IM or slow IV (diluted in 20 ml over 2 min) Child 1 mg/kg (max 50 mg) OR cimetidine Adult 300 mg IM or slow IV (diluted in 20 ml over 2 min) Child 5 mg/kg (max mg) GLUCAGON Adult 1-2 mg IM or slow IV every 5 mins if unresponsive to adrenaline, and especially if on beta-blockers Child 20 μg/kg (max 1 mg) (Watch out for vomiting and hyperglycaemia) HYDROCORTISONE (steroid) >12 yrs 200 mg IM or slow IV 6-12 yrs 100 mg IM or slow IV 1-6 yrs 50 mg IM or slow IV <1 yr 25 mg IM or slow IV Management of severe anaphylaxis (Resuscitation Council of South Africa Guidelines). 122 Current Allergy & Clinical Immunology, August 2012 Vol 25, No.3
Anaphylaxis. Ria Dindial. Photo courtesy: nhs.co.uk
Anaphylaxis Ria Dindial Photo courtesy: nhs.co.uk Question 1 A PGY-1 resident is about to present some information on Anaphylaxis. You have read this several times in Medical school and feel confident
More informationPolicy for the Treatment of Anaphylaxis in Adults and Children
Policy for the Treatment of Anaphylaxis in Adults and Children June 2008 Policy Title: Policy for the Treatment of Anaphylaxis in Adults or Children Policy Reference Number: PrimCare08/17 Implementation
More informationSpecific treatment: Antivenom (AV) Therapy
Specific treatment: Antivenom (AV) Therapy It is never too late to give antivenom provided the indications are present: Only if features of systemic envenoming are present for bites of snakes in the red
More informationCommunity presentations of anaphylaxis in Tasmania: Who is administering the adrenaline?
Volume 13 Issue 1 Article 2 Community presentations of anaphylaxis in Tasmania: Who is administering the adrenaline? Dale Edwards University of Tasmania, Hobart Melanie Blackhall University of Tasmania,
More informationManagement of an immediate adverse event following immunisation
Management of an immediate adverse event following immunisation The vaccinated person should remain under observation for a short interval to ensure that they do not experience an immediate adverse event.
More informationAcute management of anaphylaxis
Acute management of anaphylaxis These guidelines are intended for medical practitioners and nurses providing first responder emergency care. The appendix includes additional information for emergency department
More informationAnaphylaxis ASCIA Education Resources Information for health professionals
Anaphylaxis ASCIA Education Resources Information for health professionals Anaphylaxis is a rapidly evolving, generalised multi-system allergic reaction characterized by one or more symptoms or signs of
More informationAnaphylaxis/Latex Allergy
Children s Acute Transport Service CATS Clinical Guideline Anaphylaxis/Latex Allergy Document Control Information Author D Lutman Author Position Consultant Document Owner E Polke Document Owner Position
More informationEL DORADO COUNTY EMS AGENCY PREHOSPITAL PROTOCOLS
EL DORADO COUNTY EMS AGENCY PREHOSPITAL PROTOCOLS Effective: July 1, 2017 Reviewed: November 9, 2016 Revised: November 9, 2016 EMS Agency Medical Director ALLERGIC REACTION/ANAPHYLAXIS ADULT BLS TREATMENT
More informationBest Evidence: Australasian Guidelines for Management of Perioperative Anaphylaxis. Dr Helen Kolawole ANZAAG Management Guidelines Working Group
Best Evidence: Australasian Guidelines for Management of Perioperative Anaphylaxis Dr Helen Kolawole ANZAAG Management Guidelines Working Group Outline of Presentation Review of content of all Management
More informationPM-03 PED ALLERGY/ANAPHYLAXIS. Protocol SECTION: PM-03 PROTOCOL TITLE: PED ALLERGY/ANAPHYLAXIS REVISED: 01MAY2018
SECTION: PROTOCOL TITLE: REVISED: 01MAY2018 BLS SPECIFIC CARE: See General Pediatric Care Protocol PM-1 - Determine patient s color category on length based resuscitation tape (Broselow Tape) Epi Pen Protocol
More informationFive things to know about anaphylaxis
Five things to know about anaphylaxis Magdalena Berger, MD FRCPC Allergist and Clinical Immunologist New Brunswick Internal Medicine Update April 22, 2016 Disclosures None relevant to this presentation
More informationEmergency Department Guideline. Anaphylaxis
Emergency Department Guideline Inclusion criteria: 1. Acute onset of an illness (minutes to hours) with a AND (b OR c): a. Skin and/or mucosa (pruritus, flushing, hives, angioedema) b. Respiratory compromise
More informationAnaphylaxis: the killer allergy
36 Wijekoon C N, Undugodage C, Fernando D, Atapattu P, Malavige G N, Ranawaka U K Review Anaphylaxis: the killer allergy Wijekoon C N 1,4, Undugodage C 1,4, Fernando D 2,4, Atapattu P 2,4, Malavige G N
More informationVACCINE-RELATED ALLERGIC REACTIONS
VACCINE-RELATED ALLERGIC REACTIONS Management of Anaphylaxis IERHA Immunization Program September 2016 VACCINE-RELATED ADVERSE EVENTS Local reactions pain, edema, erythema Systemic reactions fever, lymphadenopathy
More informationabstract CLINICAL REPORT Guidance for the Clinician in Rendering Pediatric Care
CLINICAL REPORT Guidance for the Clinician in Rendering Pediatric Care Guidance on Completing a Written Allergy and Anaphylaxis Emergency Plan Julie Wang, MD, FAAP, a Scott H. Sicherer, MD, FAAP, a, b
More informationALLERGY AWARENESS POLICY
ALLERGY AWARENESS POLICY 1. RATIONALE Allergies are very common and increasing in Australia and New Zealand, affecting around 1 in 5 people at some time in their lives. There are many different causes
More informationFollowing up patients after treatment for anaphylaxis
Following up patients after treatment for anaphylaxis Unsworth D J. Following up patients after treatment for anaphylaxis. Practitioner 2012;256 (1749):21-24 Dr David J Unsworth PhD FRCP FRCPath Consultant
More informationCLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAXIS IN INFANTS AND CHILDREN UNDER SIXTEEN YEARS OF AGE V3.0
CLINICAL GUIDELINE FOR THE MANAGEMENT OF ANAPHYLAIS IN INFANTS AND CHILDREN UNDER SITEEN YEARS OF AGE V3.0 Page 1 of 16 1. Aim/Purpose of this Guideline 1.1. The purpose of this guideline is to provide
More informationPrescription Of Epinephrine Auto-Injectors Can We Reach A Consensus?
January 2008 Volume 101 Number 1 Ceardchumann Dochtúirí na héireann Official Journal of the Irish Medical Organisation Irish Medical Journal Supplement Established 1867 Prescription Of Epinephrine Auto-Injectors
More informationVACCINE-RELATED ALLERGIC REACTIONS
VACCINE-RELATED ALLERGIC REACTIONS Management of Anaphylaxis Public Health Immunization Program June 2018 VACCINE-RELATED ADVERSE EVENTS Local reactions pain, edema, erythema Systemic reactions fever,
More informationMyth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen
Myth: Prior Episodes Predict Future Reactions REALITY: No predictable pattern Severity depends on: Sensitivity of the individual Dose of the allergen Anaphylaxis Fatalities Estimated 500 1000 deaths annually
More informationAllergic Emergencies and Anaphylaxis. George Porfiris MD, CCFP(EM),FCFP TEGH
Allergic Emergencies and Anaphylaxis George Porfiris MD, CCFP(EM),FCFP TEGH Copyright 2017 by Sea Courses Inc. All rights reserved. No part of this document may be reproduced, copied, stored, or transmitted
More informationRecommendations on the Use of Epinephrine in Outdoor Education and Wilderness Settings
WILDERNESS & ENVIRONMENTAL MEDICINE, 21, 185 187 (2010) WILDERNESS MEDICAL SOCIETY ROUNDTABLE REPORT Recommendations on the Use of Epinephrine in Outdoor Education and Wilderness Settings The Epinephrine
More informationAnaphylaxis: Treatment in the Community
: Treatment in the Community is likely if a patient who, within minutes of exposure to a trigger (allergen), develops a sudden illness with rapidly progressing skin changes and life-threatening airway
More informationPROCEDURE FOR MANAGING AN ANAPHYLACTIC EMERGENCY
MULTIDISCIPLINARY PROCEDURE PROCEDURE FOR MANAGING AN ANAPHYLACTIC EMERGENCY First Issued June 2011 Issue Version Four Purpose of Issue/Description of Change Planned Review Date To promote safe and consistent
More informationAnaphylaxis: Exactly what you need to know. Dr. David Carr February 23 rd 2014
Anaphylaxis: Exactly what you need to know Dr. David Carr February 23 rd 2014 Disclosures I AM NOT AN ALLERGIST OR IMMUNOLOGIST But I treat acute allergic reactions nearly every single shift I also work
More informationPrimary Care practice clinics within the Edmonton Southside Primary Care Network.
Allergy/Immunotherapy Injections Last Review: November 2016 Intervention(s) and/or Procedure: Administration of allergen injections throughout immunotherapy treatment. Immunotherapy for allergic disease
More informationCARDIAC ARREST IN SPECIAL CIRCUMSTANCES 2
CARDIAC ARREST IN SPECIAL CIRCUMSTANCES 2 M1 Objectives To understand how resuscitation techniques should be modified in the special circumstances of: Hypothermia Immersion and submersion Poisoning Pregnancy
More informationSign up to receive ATOTW weekly -
ANAPHYLAXIS ANAESTHESIA TUTORIAL OF THE WEEK 38 1 th DECEMBER 2006 Dr. Sara Rees Cardiff, UK Case History You are anaesthetising a fit and well 40 year old woman for total abdominal hysterectomy for menorrhagia.
More informationFaith Lutheran College, Redlands Faith in Christ prepared for life A I ANAPHYLAXIS POLICY T H. Last updated June 2017
F Faith Lutheran College, Redlands Faith in Christ prepared for life A I ANAPHYLAXIS POLICY T H Last updated June 2017 Food Allergy Policy and Procedures Rationale: Within the general community, there
More informationAnaphylaxis 5/31/2015
1 Definition of anaphylaxis Anaphylaxis Jon Kyle Andersen Anaphylaxis is a severe, life-threatening, generalised or systemic hypersensitivity reaction. It is characterised by rapidly developing, life-threatening
More informationAnaphylaxis Webinar. Dr. Adam Dukelow Local Medical Director. Stéphanie Romano Regional Paramedic Educator. Stephanie Grant PCP Elgin-St.
Anaphylaxis Webinar Dr. Adam Dukelow Local Medical Director Stéphanie Romano Regional Paramedic Educator Stephanie Grant PCP Elgin-St.Thomas EMS Objectives Given this webinar presentation, the paramedic
More informationFINTONA GIRLS SCHOOL. Anaphylaxis Management Plan
FINTONA GIRLS SCHOOL Anaphylaxis Management Plan Fintona Girls School will fully comply with Ministerial Order 706 (2014) and the associated Guidelines published and amended by the Department from time
More informationANAPHYLAXIS EMET 2015
ANAPHYLAXIS EMET 2015 ANA = AGAINST PHYLAX = PROTECTION No standardised definition (they re working on it) All include the similar concept of: A serious, generalised or systemic, allergic or hypersensitivity
More informationFirst Aid Information
ISSUED May 2018 First Aid Information First Aid Kits Are Located: First Aid Kits Are Managed By: First Aid Kits Are Accessible By: Church Staff Ministry Volunteer Leaders Ministry Volunteer Team Members
More informationAnaphylaxis: treatment in the community
: treatment in the community Item Type Guideline Authors Health Service Executive Citation Health Service Executive. : treatment in the community. Dublin: Health Service Executive;. 5p. Publisher Health
More informationAnnex II. Scientific conclusions and grounds for variation to the terms of the marketing authorisations
Annex II Scientific conclusions and grounds for variation to the terms of the marketing authorisations 29 Scientific conclusions Overall summary of the scientific evaluation Auto-injectors were invented
More informationAllergic Reactions and Envenomations. Chapter 16
Allergic Reactions and Envenomations Chapter 16 Allergic Reactions Allergic reaction Exaggerated immune response to any substance Histamines and leukotrienes Chemicals released by the immune system Anaphylaxis
More informationSample Influenza Protocol
Sample Influenza Protocol Dear Pharmacists: The Missouri Pharmacy Association s Professional Affairs Immunization Committee has worked to develop an example written protocol for members to use as a guide
More informationS:\Admin Staff\100 Administration\2010\109 Policy\Operational Plans\Anaphylaxis Policy.doc
Growing Together Principal: Mr Paul Andrijich Deputy Principal: Mr Paul Westcott Registrar: Mrs Kerry Vine 65 Coast Road West Swan WA 6055 Telephone: 9250 2711 Mobile: 0434734390 Fax: 9250 2416 EDUCATE
More informationChapter 8. Learning Objectives. Learning Objectives 9/11/2012. Anaphylaxis. List symptoms of anaphylactic shock
Chapter 8 Anaphylaxis Learning Objectives List symptoms of anaphylactic shock Discuss role of immune system in fighting antigens Define allergic response Learning Objectives Describe body s response to
More informationImproving Self Care with Allergy New Zealand and ASCIA Resources
Improving Self Care with Allergy New Zealand and ASCIA Resources Dr Kylie Morse, Wellington GP Allergy NZ Board Member Associate Member ASCIA 1 Acknowledgements Allergy New Zealand for providing the depth
More informationDYSRHYTHMIAS. D. Assess whether or not it is the arrhythmia that is making the patient unstable or symptomatic
DYSRHYTHMIAS GENERAL CONSIDERATIONS A. The 2015 American Heart Association Guidelines were referred to for this protocol development. Evidence-based science was implemented in those areas where the AHA
More informationManagement of acute asthma in children in emergency department. Moderate asthma
152 Moderate asthma SpO2 92% No clinical features of severe asthma NB: If a patient has signs and symptoms across categories, always treat according to their most severe features agonist 2-10 puffs via
More informationDear Dr Slater RANZCR Draft Iodinated Contrast Guideline
AUSTRALIAN AND NEW ZEALAND COLLEGE OF ANAESTHETISTS A.B.N. 82 055 042 852 06 January 2016 Dr Gregory Slater Dean, Faculty of Clinical Radiology Royal Australian and New Zealand College of Radiologists
More informationA Clinical Guideline for the use of Intravenous Aminophylline in Acute Severe Asthma in Children
For Use in: By: For: Division responsible for document: Key words: Name and job titles of document author: Name and job title of document author s Line Manager: Supported by: Assessed and approved by the:
More informationStudent Health Center
Referring Allergist Agreement Your patient is requesting that the University of Mary Washington Student Health Center (UMWSHC) administer allergy extracts provided by your office. Consistent with our policies
More informationEmergency Treatment of Anaphylaxis Policy and Guidelines
Emergency Treatment of Anaphylaxis Policy and Guidelines This procedural document supersedes: PAT/EC 3 v.6 Emergency Treatment of Anaphylaxis Policy and Guidelines This procedural document should be used
More informationTREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE
TREATMENT OF ANAPHYLACTIC REACTION WITH EPINEPHRINE FILE: JGCDC Background: The Bibb County School System recognizes the growing concern with severe life-threatening allergic reactions to food items, latex,
More informationUCSF High Risk Emergency Medicine Anaphylaxis February 2019
UCSF High Risk Emergency Medicine Anaphylaxis February 2019 Corey M. Slovis, M.D. Vanderbilt University Medical Center Metro Nashville Fire Department Nashville International Airport Nashville, TN True
More informationManagement of ANAPHYLAXIS in the School Setting. Updated September 2010
Management of ANAPHYLAXIS in the School Setting Updated September 2010 What is an Allergy? Allergies occur when the immune system becomes unusually sensitive and over reacts to common substance that are
More informationIgE. Anaphylaxis is a serious allergic reaction that is rapid in onset and may cause death
Vol.21 No.1, 2014 80% 1% Vol.21 No.1, 29, 2014 I 80 1 1 2013 8 9 2013 9 6 J-STAGE 2013 12 20 135-0075 3-3-20 E-mailh-hmituhata@lares.dti.ne.jp IgE 2 Anaphylaxis is a serious allergic reaction that is rapid
More informationNunawading Christian College Secondary Anaphylaxis Management Policy
Nunawading Christian College Secondary Anaphylaxis Management Policy Document Control Revision Number Implementation Date Review Date Description of Changes Prepared By Approved By 1.2 April 2014 May 2015
More informationfirst aid information
first aid information FIRST AID TREATMENT FOR ANAPHYLAXIS Anaphylaxis is a severe allergic reaction and potentially life threatening. It should always be treated as a medical emergency, requiring immediate
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 9 May 2012
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 9 May 2012 ANAPEN 0.50 mg/0.3 ml, solution for injection in pre-filled syringe 1 pre-filled syringe (glass), box of
More informationNEWSLETTER NINETEENTH EDITION APRIL 2014 ALLSA REPORT FROM THE CHAIRMAN INSIDE THIS ISSUE APRIL 2014 NINETEENTH EDITION 1. My Dear Colleagues
NEWSLETTER NINETEENTH EDITION APRIL 2014 ALLSA REPORT FROM THE CHAIRMAN My Dear Colleagues April sees us sharing World Allergy Week along with the World Allergy Organisation. This year we chose to add
More informationTHINGS CLINICIANS AND CONSUMERS SHOULD QUESTION. Developed by the Australasian Society of Clinical Immunology and Allergy
THINGS CLINICIANS AND CONSUMERS SHOULD QUESTION Developed by the Australasian Society of Clinical Immunology and Allergy 1 Don t use antihistamines to treat anaphylaxis prompt administration of adrenaline
More information02/06/2013. Goal of program. A few definitions. Objectives of the training. Legal context. Legal context in schools
2 Goal of program Administering epinephrine for acute anaphylactic type allergic reactions Reduce the morbidity and mortality associated with acute anaphylactic type allergic reactions. Training for first
More informationTony Gray Head of Safety and Security. Tony Gray Head of Safety and Security. Contents Section Description Page No.
Health and Safety Policy Practice Guidance Note Latex Sensitivity V04 Date Issued Planned Review Issue 1 Oct 17 Oct 2020 HS-PGN-10 Part of NTW(O)20 Health and Safety Policy Author/Designation Tony Gray
More informationAdministering epinephrine for acute anaphylactic type allergic reactions
Administering epinephrine for acute anaphylactic type allergic reactions Training for first aiders People known to be allergic (1.5 hours) MAJ 2012-3 2 Objectives of the training Understand the legal context
More informationPedsCases Podcast Scripts
PedsCases Podcast Scripts This is a text version of a podcast from Pedscases.com on Anaphylaxis in Children. These podcasts are designed to give medical students an overview of key topics in pediatrics.
More informationSCHOOL DISTRICT NO. 51 (BOUNDARY) P O L I C Y
SCHOOL DISTRICT NO. 51 (BOUNDARY) P O L I C Y SECTION TITLE NO. 4020 HEALTH/SAFETY Anaphylaxis (Severe Allergic Reaction) DATE ADOPTED: May 13, 2008 DATE AMENDED: Anaphylaxis is a sudden and severe allergic
More informationMedical Emergencies and Current Management in Dentistry. Prof. Mark Greenwood Newcastle University
Medical Emergencies and Current Management in Dentistry Prof. Mark Greenwood Newcastle University Lancaster 1.02.12 PREVENTION! Attitude and environment Usually a clue in the history PREVENTION! Attitude
More informationAnaphylaxis Policy. Rationale. What is anaphylaxis?
Anaphylaxis Policy Rationale Allergic reactions are common in children. However, severe life threatening allergic reactions are uncommon and deaths are rare. Protecting our community from the effects of
More informationAnaphylaxis in the Community
Anaphylaxis in the Community ACES101210 Copyright 2010, AANMA www.aanma.org ACES2015 ACES101210 Copyright Copyright 2015 2010, Allergy AANMA & Asthma www.aanma.org Network AllergyAsthmaN Anaphylaxis Community
More informationQueen City Independent School District Stock Epinephrine Policy/Protocol
Queen City Independent School District Stock Epinephrine Policy/Protocol In accordance with Texas SB 66 as well as Chapter 38 of the Education Code Subchapter E, and the NASN guidelines for stock Epinephrine
More informationCHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL
CHANGES FOR DECEMBER 2008 PREHOSPITAL CARE MANUAL Item Changed Airway Management Procedure Oral Intubation Procedure Tube Confirmation and Monitoring Procedure C10 Chest Pain/ACS M2 Allergic Reaction/Anaphylaxis
More informationSPECIAL CONSIDERATIONS ON ANAPHYLAXIS IN LATIN AMERICA
Innovative Approaches in Anaphylaxis SPECIAL CONSIDERATIONS ON ANAPHYLAXIS IN LATIN AMERICA Edgardo J Jares, MD President-elect Sociedad Latinoamericana de Alergia Asma e Inmunología ANAPHYLAXIS Severe
More informationA lthough the term anaphylaxis was introduced as far
159 ORIGINAL ARTICLE Paediatric emergency department : different patterns from adults S C Braganza, J P Acworth, D R L Mckinnon, J E Peake, A F T Brown... Arch Dis Child 2006;91:159 163. doi: 10.1136/adc.2004.069914
More informationRecognition and Treatment of Anaphylaxis in the School Setting
Recognition and Treatment of Anaphylaxis in the School Setting Background for Authorization House Bill 1107/Senate Bill 656 enacted by the 2012 General Assembly required local school boards to adopt and
More informationSystemic Anti-Cancer Treatment (SACT) Hypersensitivity Guideline
This is an official Northern Trust policy and should not be edited in any way Systemic Anti-Cancer Treatment (SACT) Hypersensitivity Guideline Reference Number: NHSCT/12/518 Target audience: This document
More informationIntroduction: Severe adverse reactions:
Immunotherapy and Anaphylaxis: Risks, Prevention, Recognition and Treatment by Frederick M. Schaffer, M.D. Associate Professor, The Medical University of South Carolina Introduction: Immunotherapy (IT)
More informationELWOOD COLLEGE PROGRAM: ANAPHYLAXIS MANAGEMENT POLICY NO: 4 DATE: 09/02/10
ELWOOD COLLEGE Glenhuntly Rd, Elwood, 3184, Telephone 9531 9566 PROGRAM: ANAPHYLAXIS MANAGEMENT POLICY NO: 4 DATE: 09/02/10 PURPOSE: 1. To provide, as far as practicable, a safe school environment in which
More informationThe administration of epinephrine for severe anaphylactic type allergic reactions. Training for Quebec first aiders 2012-MAJ-3
The administration of epinephrine for severe anaphylactic type allergic reactions Training for Quebec first aiders 2012-MAJ-3 2 Objectives Understand the causes and mechanisms of anaphylaxis Know the symptoms
More informationCranbourne West Primary School No ANAPHYLAXIS MANAGEMENT POLICY
Draft: 9 Date: 30/5/16 Ratified: 6/6/16 Cranbourne West Primary School No. 5189 ANAPHYLAXIS MANAGEMENT POLICY RATIONALE/GENERAL STATEMENT Anaphylaxis is a severe, rapidly progressive allergic reaction
More informationEmergency treatment of anaphylaxis in adults: concise guidance
CONCISE GUIDELINES Emergency treatment of anaphylaxis in adults: concise guidance Jasmeet Soar on behalf of the multidisciplinary Guideline Development Group* ABSTRACT Anaphylaxis is a severe, life-threatening,
More informationMEDICAL KIT - ALGORITHMS
MEDICAL KIT - ALGORITHMS Page 2 : BRONCHOSPASM / ASTHMA Page 3 : TENSION PNEUMOTHORAX Page 4 : Page 5 : Page 6 : CONGESTIVE HEART FAILURE/ PULMONARY EDEMA ANAPHYLACTIC SHOCK / ALLERGIC REACTION ANGINA
More informationAnaphylaxis Independent Learning Package
Anaphylaxis Independent Learning Package What is Anaphyalxis? Anaphylaxis is a very severe allergic reaction, usually to a substance to which an individual has previously shown sensitivity. It is for this
More informationAnaphylaxis Guidelines
Anaphylaxis Guidelines 2015 FAMILY NURSING & HOME CARE RATIFICATION FORM Type i.e. Strategy, Policy, Education Package etc. Name Guideline Anaphylaxis Guidelines Category i.e. organisational, clinical,
More informationFood Allergy: A Developmental Approach
Food Allergy: A Developmental Approach Melinda Braskett, MD Keck School of Medicine at USC Children s Hospital Los Angeles Gores Family Allergy Center April 28, 2018 1 Case based discussion of FA across
More informationAdrenaline 1mg in 10mL (1:10,000) Pre-filled syringe 3 Amiodarone 300mg/10mL Pre-filled syringe 5
Quick Reference Guide for: Cardiac Arrest Medicines Box (BLUE) Please Note: Any medicines given must form part of an Airway, Breathing, Circulation, Disability and Exposure (ABCDE) Assessment (9)999 must
More informationRecommended Component: Assure Immediate Access to Medications as Prescribed
Recommended Component: Assure Immediate Access to Medications as Prescribed Students must have immediate access to all medications as approved by healthcare providers and parents, regardless of the availability
More informationRisk of recurrence in anaphylaxis in children
Risk of recurrence in anaphylaxis in children 14/01/2018 Dr Ahmad Al Shami DISCLOSURE I do not have any relevant financial relationship with commercial interest to disclose Learning Objectives Detail what
More informationEmergency Preparedness for Anaphylaxis in School
10/19/2017 Emergency Preparedness for Anaphylaxis in School Michael Corjulo APRN, CPNP, AE-C ASNC April 20, 2017 Objectives Review a brief overview of anaphylaxis related to the school environment Demonstrate
More informationARDCRONEY NATIONAL SCHOOL NUT SAFE AND ALLERGY AWARENESS POLICY
ARDCRONEY NATIONAL SCHOOL NUT SAFE AND ALLERGY AWARENESS POLICY JUNE 2018 Contents: 1: Rationale for Developing a 2: What is Anaphylaxis? 3: Successful Implementation 4: Bullying and Anaphylaxis 5: Signs
More informationPARENT/ GUARDIAN ANAPHYLAXIS PACKAGE ELEMENTARY/SECONDARY
PARENT/ GUARDIAN ANAPHYLAXIS PACKAGE ELEMENTARY/SECONDARY 2006 PARENT/GUARDIAN INFORMATION & RESPONSIBILITIES: The Board and its schools endeavor to provide a safe environment for children with life threatening
More informationGuidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings
Guidance for the Use of Subcutaneous Furosemide by Continuous Infusion for Heart Failure in Community Settings NHS Highland Authorised by: Planning For Fairness: Yes/No (Formerly EQIA) Distribution Consultant
More informationInternational consensus on (ICON) anaphylaxis
International consensus on (ICON) anaphylaxis The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Published Version Accessed
More informationAnaphylaxis: Updates on New Discovery and Clinical Guidelines
Anaphylaxis: Updates on New Discovery and Clinical Guidelines e NEWS A Peculiar Cause of Anaphylaxis: No More Steak? The Journey to Discovery of a Newly Recognized Allergy to Galactose-Alpha-1,3-Galactose
More informationAnaphylaxis. Choosing Wisely with Academic Detailing Conference October 21, 2017
Anaphylaxis Choosing Wisely with Academic Detailing Conference October 21, 2017 Disclosure Natasha Rodney-Cail, Pharmacist, Drug Evaluation Unit DEU funded by the Drug Evaluation Alliance of Nova Scotia
More informationAccommodations Request Severe Allergies Cover Sheet
Accommodations Request Severe Allergies Cover Sheet Child s Name: School Number: Director Name: School Phone #: Prospective Enrollment Date parent/guardian would like child to begin: Child Currently Enrolled
More informationAntiallergics and drugs used in anaphylaxis
Antiallergics and drugs used in anaphylaxis Antiallergics and drugs used in anaphylaxis The H 1 -receptor antagonists are generally referred to as antihistamines. They inhibit the wheal, pruritus, sneezing
More informationBeehive Science and Technology Academy Anaphylaxis / Stock Epinephrine Policy
Beehive Science and Technology Academy Anaphylaxis / Stock Epinephrine Policy 1 Table of Contents BSTA Anaphylaxis / Stock Epinephrine Policy (Severe Allergic Reaction)... 3 Policy Limitations...3 Overview...3
More informationDrew University Health Service 36 Madison Avenue Madison, New Jersey Tel: Fax:
Dear Student, Enclosed you will find our policies, procedures and student consent form for your allergy immunotherapy. We ask that you read them carefully, sign the consent form, and take the physician
More information09/17/2018. Standing Order for Influenza Vaccine for SKIIP Participants
Purpose: To reduce the morbidity and mortality of influenza by vaccinating those children and adolescents who meet the criteria established by the Centers for Disease Control and Prevention s (CDC) Advisory
More informationCardiac Catheter Labs Intravenous Drug Therapy Guide
Title of Guideline (must include the word Guideline (not protocol, policy, procedure etc) Contact Name and Job Title (author) Cardiac Catheter Lab IV Medicines Guideline Helen Buxton ( Senior Cath Lab
More informationANAPHYLAXIS POLICY. Purpose of this policy. Guidelines
Purpose of this policy ANAPHYLAXIS POLICY To ensure schools manage students at risk of anaphylaxis and meet legislative requirements. To provide, as far as practicable, a safe and supportive environment
More informationSAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY. Administration of Epinephrine Auto-Injector Training
SAN JOAQUIN COUNTY EMERGENCY MEDICAL SERVICES AGENCY Administration of Epinephrine Auto-Injector Training Disclaimer: Authorization - EMT Optional Skills Only authorized Emergency Medical Technicians (EMT)
More informationSt. Joseph s Primary School Numurkah
St. Joseph s Primary School Numurkah Anaphylaxis Procedure March 2014 Basic Beliefs: Our school community nurtures the development of the whole child. Our School is built on respect and an appreciation
More information